Patients with dementia: prevalence and type of drug-drug interactions
BackgroundPatients with Alzheimer's disease (AD) and other dementias are more frequently exposed to polymedication, mainly due to the presence of comorbidities, are particularly vulnerable to drug-related problems, and present greater risk of adverse effects due to drug-drug interactions (DDIs)...
Saved in:
Main Authors: | María Cristina Muñoz-Contreras (Author), Begoña Cerdá (Author), Francisco Javier López-Román (Author), Ignacio Segarra (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of caregivers on medication adherence management in polymedicated patients with Alzheimer's disease or other types of dementia
by: María Cristina Muñoz-Contreras, et al.
Published: (2022) -
Increased Bioavailability of β-Alanine by a Novel Controlled-Release Powder Blend Compared to a Slow-Release Tablet
by: Lydia de Salazar, et al.
Published: (2021) -
Potential High-Risk Drug-Drug Interactions Among Elderly Outpatients With Dementia: A Cross-Sectional Study
by: Felipe Ferreira, et al.
Published: (2024) -
Drug-Drug Interactions in Patients with Acute Respiratory Distress Syndrome
by: Thorsten Bischof, et al.
Published: (2024) -
Is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
by: López-Antuñano Francisco Javier
Published: (1999)